Skip to main content
. 2017 Jan 23;4(2):75–85. doi: 10.1016/j.ajur.2017.01.002

Figure 3.

Figure 3

Time to PSA progression based on PCWG2 criteria, forest plot. AA, abiraterone acetate; ECOG, Eastern cooperative oncology group; NE, not estimable; PCWG, prostate cancer working group; PSA, prostate specific antigen.